Table 2. Respiratory morbidity of hospitalized RSV bronchiolitis patients and non-hospitalized children at the age of 6 years.

Respiratory morbidityat age 6	HospitalizedRSVbronchiolitispatients	Non hospitalized	Crude			Adjusted*			Adjusted**
	(n = 159)	(n = 549)	OR	95% CI	p-value	OR	95% CI	p-value	OR	95% CI	p-value
Respiratory symptoms
Current wheeze	33/155 (21.3)	42/516 (8.1)	3.0	1.9–5.0	<0.001	3.0	1.9–5.1	<0.001	3.2	1.2–8.1	0.002
Current use of asthmamedication
Inhaled steroids	11/159 (6.9)	25/549 (6.9)	1.6	0.7–3.2	0.235	1.5	0.7–3.2	0.255	3.4	1.0–11.3	0.292
Betamimetics	17/159 (10.7)	46/549 (8.4)	1.3	0.7–2.4	0.368	1.3	0.7–2.3	0.378	2.1	0.8–5.7	0.109
Asthma
Doctor’s diagnosisasthma ever	63/158 (39.9)	58/517 (11.2)	5.2	3.5–8.0	<0.001	5.3	3.4–8.0	<0.001	5.8	2.8–11.8	<0.001
Current asthma***	34/159 (21.4)	29/549 (5.3)	4.9	2.9–8.3	<0.001	4.8	2.8–8.2	<0.001	3.1	1.3–7.5	0.010

Data are numbers (percentages) unless stated otherwise;

^*Adjusted for sex and age;

^**Adjusted for sex, age, birth weight, birth season, smoke exposure during pregnancy and during life, breastfeeding, daycare, siblings, maternal atopy, ethnicity, year of birth, and maternal educational level;

^***Defined as combination of a history of doctor’s diagnosed asthma plus asthma symptoms or medication use in the last 12 months (beta-mimetics or inhaled corticosteroids).